EUCANCan is a European-Canadian cooperation aimed at enhancing modern oncology by implementing a cultural, technological, and legal integrated framework across Europe and Canada. The framework will facilitate efficient analysis, management, and sharing of cancer genomic data.
This cooperative framework is not only expected to immediately contribute to improving biomedical research in cancer, but to also serve as a model for globalizing and enriching personalised medicine initiatives, allowing the exchange of data, clinical experience, and information across different national health systems. EUCANCan’s major efforts are directed to tackle current cultural, technical, and ethico-legal limitations that prevent the sharing and the reuse of existing and newly generated genome oncology data.
EUCANCan is part of the EUCAN cluster, which consists of the six projects that were funded under the Horizon 2020 call
A federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalised Medicine.
European Union‘s Horizon 2020 research and innovation programme
1 January 2019 – 31 December 2022 (48 months
Prof David Torrents, Barcelona Supercomputing Center (BSC)
18 partners across Europe and Canada